BlueWind Medical was preparing to launch Revi™, a first-of-its-kind implantable tibial neuromodulation system for Urge Urinary Incontinence (UUI).
We knew that trust in MedTech is built, not bought—especially in a space as intimate and underserved as women’s bladder health. We built our launch around credibility and clinical impact, using press, peer-reviewed studies, and expert voices to tell the story.
Marketing Comms: From Awareness to Action
Once credibility was established, we shifted focus to multi-channel owned and paid communications:
Patient Messaging:
Empathetic, empowering language like “Take control on your terms” highlighted Revi’s ease, discretion, and life-changing potential.
Provider Materials:
Reimbursement guidance, efficacy stats (78% leak reduction at 2 years), and implant simplicity supported informed clinical decision-making.
Results:
Earned media impressions: 15M+ in top-tier trade and health press
HCP interest surged, with over 100 new inquiries in the first 90 days
Early adopters drove strong patient satisfaction and ongoing word-of-mouth
Why It Worked:
Revi entered the market not as a gimmick but as a game-changer. By leading with earned credibility and supporting it with innovative, human-focused creativity, we helped BlueWind redefine what’s possible in bladder health care.
Revi entered the market not as a gimmick but as a game-changer. By leading with earned credibility and supporting it with innovative, human-focused creativity, we helped BlueWind redefine what’s possible in bladder health care.
